(210) | Number of the EPO application | 16779363 |
(220) | Filing date of the EPO application | 2016.04.13 |
(80) | EPO patent specification publication (B) | EPB nr. 01/2020, 2020.01.01 |
(110) | EPO patent number | 3283067 |
(11) | Number of the document | MD 3283067 T2 |
(21) | Number of the application | e 2018 0191 |
(71) | Name(s) of applicant(s), code of the country | Milestone Pharmaceuticals Inc., CA; |
(72) | Name(s) of inventor(s), code of the country | MAGUIRE Martin P., US; |
(73) | Name(s) of owner(s), code of the country | MILESTONE Pharmaceuticals Inc., CA; |
(54) | Title of the invention | Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | A61K 31/277 (2006.01.01); A61K 9/08 (2006.01.01); A61K 9/00 (2006.01.01); A61P 25/06 (2006.01.01); A61P 9/00 (2006.01.01); A61P 9/06 (2006.01.01); A61P 9/10 (2006.01.01); C07C 255/42 (2006.01.01); A61K 47/20 (2006.01.01); A61K 47/18 (2017.01.01); A61K 47/12 (2006.01.01) |
(19) | Country | CA |
(41) | Date of publication of the application | 2018.04.30 |
(49) | Date of publication of the translation of the validated European patent specification | 2020.05.31 |
(30) | Priority | 201562147427 P, 2015.04.14, US |
(74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
(86) | International application | PCT/CA2016/050425, 2016.04.13 |
(87) | International publication | WO 2016/165014, 2016.10.20 |